On December 31, 2014, Knowles Corporation (NYSE:KN) entered into an Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”) among the Company, Knowles Luxembourg International S. r.l. and certain other subsidiaries of the Company, as borrowers, the lenders named therein and JPMorgan Chase Bank, N.A., as administrative agent (the “Agent”), comprised of a $350 million five-year senior secured revolving credit facility and a $300 million five-year senior secured term loan facility. The Amended and Restated Credit Agreement amends and restates the Credit Agreement (the “Original Credit Agreement”) dated January 27, 2014 among the Company and certain subsidiaries of the Company, as borrowers, the lenders named therein and the Agent. On Friday shares of Knowles Corporation (NYSE:KN) closed at $24.67. Company’s EPS growth for next 5 years is recorded as 15.00%.
The General Counsel, Sec. and VP, of Zynga Inc (NASDAQ:ZNGA) Shah Devang had unloaded 10,177 shares at $2.4 per share in a transaction on December 16, 2014. The total value of transaction was $24,425. Zynga Inc (NASDAQ:ZNGA) in last trading activity advanced 2.33% to close at $2.64. Company weekly performance is -3.30% while its quarterly performance stands at 10.00%. Zynga Inc (NASDAQ:ZNGA) is -55.18% away from its 52 week high.
BIND Therapeutics, Inc. (NASDAQ:BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, on 7 January announced its 2015 strategic overview and enrollment of the first patient expressing a KRAS mutation in a global, multicenter two-tiered phase 2 trial with BIND-014 in non-small cell lung cancer (NSCLC) patients with KRAS mutant tumors (mutated Kirsten ras oncogene homolog) or squamous histology.On last trading day BIND Therapeutics, Inc. (NASDAQ:BIND) advanced 2.12% to close at $7.21. Its volatility for the week is 17.22% while volatility for the month is 7.73%. BIND Therapeutics, Inc. (NASDAQ:BIND) monthly performance is 26.27%.
Executive VP, Client Services of Textura Corporation (NYSE:TXTR) Antis Michael had purchased shares worth of $24,970 in a transaction dated on December 8, 2014. A total of 908 shares were purchased at a price of $27.5 per share. Textura Corporation (NYSE:TXTR) has 1.90% insider ownership while its institutional ownership stands at 77.60%. In last trading activity company’s stock closed at $28.56.
Jefferies Group restated their hold rating on shares of Chuy’s Holdings (NASDAQ:CHUY) in a report issued on Tuesday. They currently have a $22.00 target price on the stock, down from their previous target price of $26.00.On last trading day Chuy’s Holdings, Inc. (NASDAQ:CHUY) advanced 0.15% to close at $20.38. Its volatility for the week is 4.12% while volatility for the month is 3.73%. CHUY’s sales growth for past 5 years was 31.50%. Chuy’s Holdings, Inc. (NASDAQ:CHUY) monthly performance is -4.14%.